Blake A. Morrison Discusses the Excitement in Myeloma Research

Blake A. Morrison discusses the recent excitement in myeloma research.

Blake A. Morrison, vice president, Medical and Scientific Affairs, Multiple Myeloma Research Foundation, discusses the recent excitement in myeloma research.

Morrison touches on the approvals of Empliciti (elotuzumab), Ninlaro (ixazomib) and Darzalex (daratumumab), as well as the research into CAR T cell immunotherapy.

Read more of our coverage from the 2015 ASH Annual Meeting

Related Content:

CURE TVMyeloma
A New Line of Defense in Blood Cancer: Natural Killer Cell Therapy
It Takes a Village: Cancer Caregivers Need to Care for Themselves, Too
It Takes Teamwork to Treat Myeloma, and Patients Are Key Players